This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Francine E Lui: Innovator in Hemoglobin Research
Introduction
Francine E Lui is a prominent inventor based in Toronto, Canada. She has made significant contributions to the field of medical research, particularly in the development of compounds that enhance the oxygen-binding affinity of hemoglobin. Her work is crucial for addressing various health conditions, including sickle cell disease and high altitude tissue hypoxia.
Latest Patents
Francine E Lui holds a patent for her invention titled "Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin." This invention relates to compounds of Formula I and pharmaceutically acceptable salts thereof, which serve as allosteric effectors. These compounds are designed to increase the oxygen-binding affinity of hemoglobin, making them useful in treating sickle cell disease, high altitude tissue hypoxia, and other related conditions. She has 1 patent to her name.
Career Highlights
Francine E Lui is associated with The General Hospital Corporation, where she continues her research and development efforts. Her work has garnered attention for its potential impact on improving patient outcomes in various medical scenarios.
Collaborations
Throughout her career, Francine has collaborated with notable professionals in her field, including Warren M Zapol and Kenneth D Bloch. These collaborations have furthered her research and contributed to the advancement of medical science.
Conclusion
Francine E Lui is a dedicated inventor whose work in hemoglobin research has the potential to transform treatments for serious health conditions. Her innovative approach and commitment to medical advancements highlight her importance in the field of research and development.